newsfilter
← Latest News
Business Wire·

Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights

- Launched strategic clinical site partnerships to accelerate PARADIGM, a multinational pivotal Phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder ("MDD") - - PARADIGM